access and delivery partnership

Name

access and delivery partnership

Legal name

Access and Delivery Partnership

Website

https://adphealth.org

Company type

Private

Founded year

2013

Operating status

Operating

Ownership category

akta.pro rank

Product category

Global Health Development Services

SIC

Services-Health Services (8000)

akta.pro primary industry

Global Health Research, Clinical Trials & Product Development Partnerships (PDPs) (HLAJAOAM)

Keywords

• Global health partnership
• Health system strengthening
• Access to medicines
• Implementation research
• Regulatory capacity building

Headquarters

HQ city

Geneva/New York (UN system)

Offices2 records

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Technology or R&D, Infrastructure, Marketing or Sales

Revenue model

1. Development Assistance / Grant Funding: ADP is funded by the Government of Japan and operates as a development partnership. The partnership does not generate commercial revenue but receives funding to strengthen health systems in low- and middle-income countries.

Go-to-market motion2 records

Distribution channels3 records

Marketing channels7 records

Core offering

Access and Delivery Partnership (ADP) is a multi-stakeholder development initiative that strengthens capacity in low- and middle-income countries to access and deliver life-saving health technologies — medicines, vaccines, and diagnostic tools — with emphasis on tuberculosis, malaria, and neglected tropical diseases. ADP delivers technical assistance, capacity building, regulatory harmonization support, and digital health solutions through its core implementing partners (UNDP, WHO, TDR, PATH), funded by the Government of Japan.

Product overview

The Access and Delivery Partnership (ADP) operates as a multi-partner initiative (UNDP, WHO, TDR, PATH) focused on ensuring access to life-saving health technologies in low- and middle-income countries. Rather than offering a single software product, ADP provides a portfolio of knowledge products, toolkits, and digital health solutions. The core offerings include the Digital Health for Development Hub (a platform for scaling digital health), the Implementation Research Toolkit (for standardized implementation research), and country-specific digital solutions like SMILE (Indonesia's immunization supply chain system). These offerings work together to strengthen health systems from regulatory frameworks to supply chains and last-mile delivery for TB, malaria, and neglected tropical diseases.

Differentiator

Problem solved

Functional benefit

Products and services

• Digital Health for Development Hub A one-stop shop platform providing technical, advisory and partnership support for scaling up digital health solutions across low- and middle-income countries, targeting governments and digital health stakeholders.
• Implementation Research Toolkit A toolkit designed to help teams conduct implementation research projects through a standardized process to ensure reliable, high-quality results in health technology access and delivery.
• SMILE (Sistem Monitoring Imunisasi Logistik secara Elektronik) Indonesia's innovative digital solution that strengthens immunization supply chain systems by providing real-time, reliable data on vaccine stocks and improving economic efficiency in vaccine distribution for the Government of Indonesia.
• Toolkit for ensuring rights-based and ethical use of digital technologies in HIV and Health programmes A practical guidance toolkit for UN staff, governments, partners, technology developers, and civil society organizations for implementing ethical and rights-based digital health solutions in HIV and health programmes.
• Pipeline Analysis A comprehensive survey working paper of new medicines, diagnostics and vaccines for malaria, tuberculosis and selected neglected tropical diseases that were in the pipeline for market entry.

Quantifiable outcome

• Reduced regulatory approval time from 2 years to 7 months through harmonization efforts
• +3 more outcomes

Named customers6 records

Segments4 records

Ideal customer profiles4 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

AI capability6 records

Feature7 records

Partnerships

13 partnerships are on record, tiered core/lead, core, key, supporting and emerging.

• United Nations Development Programme (UNDP)core/leadStrategic or Co-development Partner · 1 January 2013UNDP serves as the lead implementing agency for ADP, coordinating the partnership and leveraging its development expertise to strengthen health systems in low- and middle-income countries. The partnership is funded by the Government of Japan and has been operating since 2013.
• World Health Organization (WHO)coreStrategic or Co-development PartnerWHO contributes normative guidance, regulatory expertise, and technical standards to the partnership, helping to strengthen regulatory frameworks and policies for health technology access.
• Special Programme for Research and Training in Tropical Diseases (TDR)coreStrategic or Co-development PartnerTDR brings research and training capabilities to strengthen implementation research capacity and support evidence-based health technology deployment.
• PATHcoreStrategic or Co-development PartnerPATH contributes expertise in health technology innovation and delivery, helping to accelerate the introduction and scale-up of health technologies in partner countries.
• Global Health Innovative Technology (GHIT) FundkeyStrategic or Co-development PartnerGHIT Fund co-hosted TICAD 9 thematic event with ADP/UNDP. The fund drives R&D for neglected diseases including malaria, TB, and NTDs through a unique public-private model, and partners with ADP on access planning for new health technologies.
• African Union Development Agency (AUDA-NEPAD)keyStrategic or Co-development PartnerADP collaborates with AUDA-NEPAD to strengthen African Medicines Regulatory Harmonization (AMRH) initiative and support establishment of the African Medicines Agency (AMA).
• Pediatric Praziquantel ConsortiumkeyStrategic or Co-development PartnerThe Consortium collaborated on introducing the first-ever treatment for preschool-aged children with schistosomiasis, supporting the landmark pilot in Tanzania.
• National Institute for Medical Research (Tanzania)keyImplementation/ SI/ Consulting PartnerImplementation partner leading the schistosomiasis treatment pilot in Tanzania, working closely with WHO, TDR, and PATH.
• Merck KGaA, Darmstadt, GermanysupportingOthersSupplier of medicines (ar praziquantel) for the preschool schistosomiasis treatment pilot implementation.
• H3D (University of Cape Town)keyStrategic or Co-development PartnerAfrican drug discovery center leveraging AI for malaria and TB drug metabolism research, representing African-led innovation in health technology development.
• NEC CorporationsupportingTechnology or IntegrationPrivate sector partner deploying biometric and digital tools in Ghana and Bangladesh through public-private partnerships, contributing to meaningful innovation at community level.
• West and Central African Regional Networks for TB ControlkeyStrategic or Co-development PartnerNetwork of 24 countries collaborating on TB control, through which ADP provides support for drug-resistant TB treatment expansion and South-South knowledge exchange.
• Japan Institute for Health SecurityemergingStrategic or Co-development PartnerRecently launched institute representing Japan's milestone in strengthening infectious disease research and global health collaboration.

Scale indicators11 records

Recent moves6 records

Expansion highlights5 records

Direct peers

• GAVI, the Vaccine Alliance: GAVI is a public-private partnership that accelerates access to vaccines in lower-income countries, with comparable focus on health technology access, regulatory capacity, and country-level implementation—directly overlapping with ADP's mandate around vaccine introduction (e.g., malaria vaccine rollout).
• The Global Fund to Fight AIDS, Tuberculosis and Malaria: The Global Fund is a multi-stakeholder financing partnership targeting the same three disease areas as ADP (TB, malaria, HIV) with country-level grants, donor convening, and similar UN-affiliated governance models, making it the most directly comparable peer.
• UNITAID: UNITAID invests in innovations to prevent, diagnose, and treat HIV/AIDS, tuberculosis, and malaria, and operates through a hosted partnership within WHO—closely mirroring ADP's WHO partnership and product-development-partnership (PDP) approach to expanding health technology access.
• Drugs for Neglected Diseases initiative (DNDi): DNDi is a collaborative PDP developing new treatments for neglected diseases (malaria, NTDs), with an explicit focus on LMIC access and delivery—directly aligned with ADP's mission around access and delivery of NTD/malaria health technologies.
• Global Health Innovative Technology (GHIT) Fund: GHIT is a Japanese public-private R&D fund focused on malaria, TB, and NTDs—sharing ADP's Japan-funder DNA and co-hosting the TICAD 9 thematic event with ADP, making it both a partner and the most thematically comparable peer in the global health innovation space.
• Medicines Patent Pool: MPP is a UN-backed public health organization working to increase access to medicines in LMICs through voluntary licensing and technology transfer—a comparable access-and-delivery mandate for health technologies serving overlapping disease areas and geographies.
• PATH: PATH is one of ADP's four core partners and an independent global health innovation organization with deep expertise in health technology introduction and delivery, making it both a consortium partner and a directly comparable peer in the same operating space.

Regional players

• African Union Development Agency (AUDA-NEPAD): AUDA-NEPAD is a regional development partner of ADP coordinating the African Medicines Regulatory Harmonization (AMRH) initiative and the African Medicines Agency—directly comparable in the regulatory harmonization domain and serving the same African focus geographies.

Broad incumbents

• World Health Organization (WHO): WHO is a core ADP partner and the broader incumbent in global health normative guidance, with overlapping mandates around NTDs, TB, malaria, and regulatory frameworks—providing the umbrella institution whose standards ADP operationalizes in focus countries.
• World Bank Global Financing Facility (GFF): GFF is a World Bank-hosted multi-stakeholder partnership financing reproductive, maternal, and child health in LMICs—sharing the partnership model, donor convening approach, and country-level implementation focus, though operating at broader health-systems scale.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks2 records

Key highlights7 records

Customer concentration

• LinkedInlinkedin.com/groups/15818027
• Xx.com/ADP_health

Revenue estimate

Valuation estimate

Number of profiles

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about access and delivery partnership